Our clinical-academic collaborative partnership is the foundation of our success. From mature technologies already on the market and improving patient care, to a vibrant spinout company portfolio to our emerging technologies, we have an excellent track record of supporting the pathway to clinical adoption.
A small selection of our technologies are presented here and others can be found in the capabilities pages or use the search function to find out what we're doing in different clinical areas.
Our Magnetoencephalography (MEG) scanner is revolutionising brain imaging with new wearable sensors and is being brought to market by Cerca Magnetics Ltd
Our facial and voice recognition technology can assist with the diagnosis and monitoring of mental health conditions, being commercialised by BlueSkye AI Ltd
Our endotracheal tube aims to minimize tracheal injury during intubation and reduce the incidence of ventilator-assisted pneumonia.
We are developing 3D-printed personalised medicines capable of delivering multiple medications at the correct dose and time.
Technologies in clinical use
General practitioners are better equipped to reduce the human and societal cost of prescription errors following a national roll-out of the PINCER tool
The SurePulse optical sensor will enhance resuscitation of babies in neonatal intensive care, and supporting clinical staff to make confident time critical decisions
Trauma patients rushed to A&E with serious eye injuries can now benefit from NuVision's ground-breaking sight-saving wound dressing
Spin-out company, Monica Healthcare, developed a technology for monitoring expectant mothers, which has been used by over 100,000 patients worldwide. Monica was bought by GE Healthcare in 2017.
Bactiseal(R) antimicrobial catheters, commercialised by Codman have dramatically cut infection rates for over a million hydrocephalus patients worldwide.
High-speed imaging is transforming the outcomes of thousands of children each year who are rushed to hospital with burns injuries
A to Z of Case Studies
- Antimicrobial technology embedded into hydrocephalus shunts is treating over 1,000,000 hydrocephalus patients worldwide, reducing infection rates since 2003. This mature and proven technology is now being explored for new clinical applications.